PT2264060E - Composições e processos para inibição da adesão viral - Google Patents

Composições e processos para inibição da adesão viral Download PDF

Info

Publication number
PT2264060E
PT2264060E PT101892776T PT10189277T PT2264060E PT 2264060 E PT2264060 E PT 2264060E PT 101892776 T PT101892776 T PT 101892776T PT 10189277 T PT10189277 T PT 10189277T PT 2264060 E PT2264060 E PT 2264060E
Authority
PT
Portugal
Prior art keywords
compositions
methods
inhibiting viral
viral adhesion
adhesion
Prior art date
Application number
PT101892776T
Other languages
English (en)
Inventor
Jan Holgersson
Original Assignee
Recopharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recopharma Ab filed Critical Recopharma Ab
Publication of PT2264060E publication Critical patent/PT2264060E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2796/00—Viruses not covered by groups C12N2710/00 - C12N2795/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT101892776T 2006-01-26 2007-01-26 Composições e processos para inibição da adesão viral PT2264060E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76279606P 2006-01-26 2006-01-26

Publications (1)

Publication Number Publication Date
PT2264060E true PT2264060E (pt) 2014-07-28

Family

ID=38653386

Family Applications (1)

Application Number Title Priority Date Filing Date
PT101892776T PT2264060E (pt) 2006-01-26 2007-01-26 Composições e processos para inibição da adesão viral

Country Status (9)

Country Link
US (3) US20070184065A1 (pt)
EP (4) EP2264060B1 (pt)
JP (3) JP5199886B2 (pt)
AU (1) AU2007251256B2 (pt)
CA (1) CA2635011A1 (pt)
DK (1) DK2264060T3 (pt)
ES (1) ES2502966T3 (pt)
PT (1) PT2264060E (pt)
WO (1) WO2007132355A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100111275A (ko) * 2008-01-03 2010-10-14 메사츄세츠 인스티튜트 어브 테크놀로지 유인 인플루엔자 치료제
WO2010010948A1 (ja) * 2008-07-25 2010-01-28 国立大学法人 群馬大学 血液型関連物質を用いたノロウイルスの感染防御又は除去
WO2013119668A1 (en) * 2012-02-06 2013-08-15 Massachusetts Institute Of Technology Mucins as antiviral compounds
US9452198B2 (en) 2012-04-23 2016-09-27 Massachusetts Institute Of Technology Lectin conjugates for mucin hydration
WO2016130498A1 (en) 2015-02-10 2016-08-18 Massachusetts Institute Of Technology Isolated mucins and different microoorganisms, and methods of use
JP7084627B2 (ja) * 2018-06-06 2022-06-15 株式会社マナＨｓコーポレーション ウイルス感染症予防用組成物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4544545A (en) * 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US4710761A (en) 1985-07-09 1987-12-01 American Telephone And Telegraph Company, At&T Bell Laboratories Window border generation in a bitmapped graphics workstation
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US5328470A (en) 1989-03-31 1994-07-12 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US6136310A (en) 1991-07-25 2000-10-24 Idec Pharmaceuticals Corporation Recombinant anti-CD4 antibodies for human therapy
US5516964A (en) 1994-01-21 1996-05-14 Sun Company, Inc. (R&M) Hydrocarbon isomerization using solid superacid catalysts comprising platinum metal
US5705364A (en) * 1995-06-06 1998-01-06 Genentech, Inc. Mammalian cell culture process
SE9701127D0 (sv) * 1997-03-26 1997-03-26 Karolinska Innovations Ab Antigenic fusionprotein carrying GALal, 3GAL epitopes
US7029872B2 (en) * 2000-06-28 2006-04-18 Glycofi, Inc Methods for producing modified glycoproteins
US7355017B2 (en) * 2001-07-20 2008-04-08 Absorber Ab Blood group antigen fusion polypeptides and methods of use thereof
AU2003233008B2 (en) * 2002-04-22 2008-04-24 Recopharma Ab Fusion polypeptides and methods for inhibiting microbial adhesion
WO2003088996A2 (en) * 2002-04-22 2003-10-30 Recopharma Ab Lewis y epitope modified polypeptide, or mucin fusion polypetide, tumor vaccines
EP1517700B1 (en) * 2002-04-22 2012-03-28 Recopharma AB Mucin fusion polypeptide vaccines, compositions and methods of use thereof
JP4648001B2 (ja) * 2002-08-09 2011-03-09 レコファーマ アーベー ムチン−免疫グロブリン融合タンパク質
AU2005337047A1 (en) * 2004-10-14 2007-04-12 Recopharma Ab Composition and methods for inhibiting H. pylori adhesion and infection

Also Published As

Publication number Publication date
US20140256019A1 (en) 2014-09-11
DK2264060T3 (da) 2014-07-28
JP2009528270A (ja) 2009-08-06
JP2012214522A (ja) 2012-11-08
WO2007132355A3 (en) 2008-04-24
US20070184065A1 (en) 2007-08-09
JP2013064016A (ja) 2013-04-11
EP2264060A1 (en) 2010-12-22
EP2781524A1 (en) 2014-09-24
ES2502966T3 (es) 2014-10-06
JP5199886B2 (ja) 2013-05-15
EP1973941A2 (en) 2008-10-01
AU2007251256A1 (en) 2007-11-22
EP2264061A1 (en) 2010-12-22
US20120020969A1 (en) 2012-01-26
EP2264060B1 (en) 2014-04-23
AU2007251256B2 (en) 2013-03-07
CA2635011A1 (en) 2007-11-22
WO2007132355A2 (en) 2007-11-22

Similar Documents

Publication Publication Date Title
EP1978975A4 (en) COMPOSITION FOR INHIBITING ADHESION
HRP20160410T8 (hr) Inhibitori hepatitis c virusa
IL195619A0 (en) Compositions and methods for joininig non-conjoined iumens
EP2010117A4 (en) COMPOSITIONS AND METHODS FOR ADHESION INHIBITION
HK1137670A1 (en) Compositions and methods for arthrodetic procedures
EP2101731A4 (en) PROCESSES AND COMPOSITIONS WITH END OXIFES
IL193151A0 (en) Viral polymerase inhibitors
SI2094702T1 (sl) Virusni inhibitorji
HK1215037A1 (zh) 流感抑制組合物和方法
GB0721291D0 (en) Methods and compositions
EP2088865A4 (en) METHODS AND COMPOSITIONS AROUND GUGGULPHOSPHOLIPIDS
GB0617171D0 (en) Novel compositions and methods
GB0605247D0 (en) Compositions and methods for immunisation
IL197023A0 (en) Viral polymerase inhibitors
PT2264060E (pt) Composições e processos para inibição da adesão viral
GB0719526D0 (en) Compositions and methods
EP1901752A4 (en) COMPOSITIONS AND METHODS FOR VIRAL INHIBITION
EP2183380A4 (en) METHODS AND COMPOSITIONS FOR PCR
ZA200903379B (en) Hepatitis C virus inhibitors
HUS1500008I1 (hu) Hepatitis C vírus inhibitorok
GB0616269D0 (en) Methods and compositions
GB0625230D0 (en) Compositions and methods
GB0607565D0 (en) Methods and compositions
AU2006906693A0 (en) Viral inhibitors
GB0608545D0 (en) Process and compositions